{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:41:45Z","timestamp":1790487705470,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007721","name":"Cure SMA","doi-asserted-by":"publisher","award":["MU1415"],"award-info":[{"award-number":["MU1415"]}],"id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["417757"],"award-info":[{"award-number":["417757"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000723","name":"Tenovus","doi-asserted-by":"publisher","award":["E15\/4"],"award-info":[{"award-number":["E15\/4"]}],"id":[{"id":"10.13039\/501100000723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000871","name":"Newlife Foundation for Disabled Children","doi-asserted-by":"publisher","award":["SG\/14-15\/08"],"award-info":[{"award-number":["SG\/14-15\/08"]}],"id":[{"id":"10.13039\/501100000871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fight SMA"},{"name":"Euan McDonald Centre for Motor Neuron Disease Research"},{"DOI":"10.13039\/100012070","name":"Anatomical Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012070","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinal Muscular Atrophy (SMA) is a childhood motor neuron disease caused by mutations or deletions within the <jats:italic>SMN1<\/jats:italic> gene. At endstages of disease there is profound loss of motor neurons, loss of axons within ventral roots and defects at the neuromuscular junctions (NMJ), as evidenced by pathological features such as pre-synaptic loss and swelling and post-synaptic shrinkage. Although these motor unit defects have been widely described, the time course and interdependancy of these aspects of motor unit degeneration are unclear. Recent reports have also revealed an early upregulation of transcripts associated with the P53 signalling pathway. The relationship between the upregulation of these transcripts and pathology within the motor unit is also unclear. In this study, we exploit the prolonged disease timecourse and defined pre-symptomatic period in the <jats:italic>Smn<\/jats:italic><jats:sup><jats:italic>2B\/<\/jats:italic><\/jats:sup><jats:sup>\u2212<\/jats:sup> mouse model to perform a temporal analysis of the different elements of motor unit pathology. We demonstrate that NMJ loss occurs prior to cell body loss, and coincides with the onset of symptoms. The onset of NMJ pathology also coincides with an increase in P53-related transcripts at the cell body. Finally, using a tamoxifen inducible P53 knockout, we demonstrate that post-natal reduction in P53 levels can reduce NMJ loss, but does not affect other aspects of NMJ pathology, motor neuron loss or the phenotype of the <jats:italic>Smn<\/jats:italic><jats:sup><jats:italic>2B\/\u2212<\/jats:italic><\/jats:sup> mouse model. Together this work provides a detailed temporal description of pathology within motor units of an SMA mouse model, and demonstrates that NMJ loss is a P53-dependant process. This work supports the role for P53 as an effector of synaptic and axonal degeneration in a die-back neuropathy.<\/jats:p>","DOI":"10.1038\/s41419-019-1727-6","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:31:36Z","timestamp":1562250696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy"],"prefix":"10.1038","volume":"10","author":[{"given":"Natalie L.","family":"Courtney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alannah J.","family":"Mole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison K.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"1727_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/hmg\/4.4.631","volume":"4","author":"NR Rodrigues","year":"1995","unstructured":"Rodrigues, N. R. et al. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum. Mol. Genet. 4, 631\u2013634 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"1727_CR3","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00439-012-1171-5","volume":"131","author":"TW Bebee","year":"2012","unstructured":"Bebee, T. W., Dominguez, C. E. & Chandler, D. S. Mouse models of SMA: tools for disease characterization and therapeutic development. Hum. Genet. 131, 1277\u20131293 (2012).","journal-title":"Hum. Genet."},{"key":"1727_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2174\/15665240113139990044","volume":"13","author":"BB Goulet","year":"2013","unstructured":"Goulet, B. B., Kothary, R. & Parks, R. J. At the \u201cjunction\u201d of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression. Curr. Mol. Med. 13, 1160\u20131174 (2013).","journal-title":"Curr. Mol. Med."},{"key":"1727_CR5","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"S Tisdale","year":"2015","unstructured":"Tisdale, S. & Pellizzoni, L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J. Neurosci. 35, 8691\u20138700 (2015).","journal-title":"J. Neurosci."},{"key":"1727_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/hmg\/ddm367","volume":"17","author":"LM Murray","year":"2008","unstructured":"Murray, L. M. et al. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17, 949\u2013962 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1727_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","volume":"11","author":"C Cifuentes-Diaz","year":"2002","unstructured":"Cifuentes-Diaz, C. et al. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum. Mol. Genet. 11, 1439\u20131447 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"1727_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40478-015-0231-1","volume":"3","author":"LM Murray","year":"2015","unstructured":"Murray, L. M., Beauvais, A., Gibeault, S., Courtney, N. L. & Kothary, R. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b\/\u2212) mouse model of spinal muscular atrophy. Acta Neuropathol. Commun. 3, 55 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"1727_CR9","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1016\/j.celrep.2017.12.003","volume":"21","author":"CM Simon","year":"2017","unstructured":"Simon, C. M. et al. Converging mechanisms of p53 activation drive motor neuron degeneration in spinal muscular atrophy. Cell Rep. 21, 3767\u20133780 (2017).","journal-title":"Cell Rep."},{"issue":"3","key":"1727_CR10","doi-asserted-by":"publisher","first-page":"e1410","DOI":"10.1002\/wrna.1410","volume":"8","author":"Ritu Chaudhary","year":"2016","unstructured":"Chaudhary, R. & Lal, A. Long noncoding RNAs in the p53 network. Wiley Interdiscip. Rev. RNA 8, https:\/\/doi.org\/10.1002\/wrna.1410 (2017).","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"key":"1727_CR11","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1038\/onc.2015.25","volume":"34","author":"V Marcel","year":"2015","unstructured":"Marcel, V., Catez, F. & Diaz, J. J. p53, a translational regulator: contribution to its tumour-suppressor activity. Oncogene 34, 5513\u20135523 (2015).","journal-title":"Oncogene"},{"key":"1727_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-981-10-1498-7_13","volume":"927","author":"Y Mei","year":"2016","unstructured":"Mei, Y. & Wu, M. Noncoding RNAs regulating p53 and c-Myc signaling. Adv. Exp. Med. Biol. 927, 337\u2013365 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"1727_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/cancers10050152","volume":"10","author":"Virginie Marcel","year":"2018","unstructured":"Marcel, V., Nguyen Van Long, F. & Diaz, J. J. 40 years of research put p53 in translation. cancers 10, https:\/\/doi.org\/10.3390\/cancers10050152 (2018).","journal-title":"Cancers"},{"key":"1727_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000329999","volume":"9","author":"JR Chang","year":"2012","unstructured":"Chang, J. R. et al. Role of p53 in neurodegenerative diseases. Neurodegener. Dis. 9, 68\u201380 (2012).","journal-title":"Neurodegener. Dis."},{"key":"1727_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-510X(97)00131-7","volume":"152","author":"SM de la Monte","year":"1997","unstructured":"de la Monte, S. M., Sohn, Y. K. & Wands, J. R. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer\u2019s disease. J. Neurol. Sci. 152, 73\u201383 (1997).","journal-title":"J. Neurol. Sci."},{"key":"1727_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1006\/nbdi.2000.0314","volume":"7","author":"LJ Martin","year":"2000","unstructured":"Martin, L. J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 7, 613\u2013622 (2000).","journal-title":"Neurobiol. Dis."},{"key":"1727_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874375701004010011","volume":"4","author":"S Ranganathan","year":"2010","unstructured":"Ranganathan, S. & Bowser, R. p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. Open Pathol. J. 4, 11\u201322 (2010).","journal-title":"Open Pathol. J."},{"key":"1727_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14336\/AD.2016.1120","volume":"8","author":"A Szybinska","year":"2017","unstructured":"Szybinska, A. & Lesniak, W. P53 dysfunction in neurodegenerative diseases - the cause or effect of pathological changes? Aging Dis. 8, 506\u2013518 (2017).","journal-title":"Aging Dis."},{"key":"1727_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26397-2","volume":"8","author":"MA Vogt","year":"2018","unstructured":"Vogt, M. A. et al. TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons. Sci. Rep. 8, 8097 (2018).","journal-title":"Sci. Rep."},{"key":"1727_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnen\/59.5.398","volume":"59","author":"G Simic","year":"2000","unstructured":"Simic, G. et al. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease. J. Neuropathol. Exp. Neurol. 59, 398\u2013407 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1727_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000773","volume":"5","author":"D Baumer","year":"2009","unstructured":"Baumer, D. et al. Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet. 5, e1000773 (2009).","journal-title":"PLoS Genet."},{"key":"1727_CR22","doi-asserted-by":"publisher","first-page":"E2347","DOI":"10.1073\/pnas.1613181114","volume":"114","author":"M Jangi","year":"2017","unstructured":"Jangi, M. et al. SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage. Proc. Natl Acad. Sci. USA 114, E2347\u2013E2356 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1727_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ygeno.2015.01.007","volume":"105","author":"JF Staropoli","year":"2015","unstructured":"Staropoli, J. F. et al. Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7. Genomics 105, 220\u2013228 (2015).","journal-title":"Genomics"},{"key":"1727_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","volume":"133","author":"Z Zhang","year":"2008","unstructured":"Zhang, Z. et al. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133, 585\u2013600 (2008).","journal-title":"Cell"},{"key":"1727_CR25","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1074\/jbc.M108769200","volume":"277","author":"PJ Young","year":"2002","unstructured":"Young, P. J. et al. A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J. Biol. Chem. 277, 2852\u20132859 (2002).","journal-title":"J. Biol. Chem."},{"key":"1727_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1385\/NMM:3:3:159","volume":"3","author":"CP Gilman","year":"2003","unstructured":"Gilman, C. P. et al. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromolecular Med. 3, 159\u2013172 (2003).","journal-title":"Neuromolecular Med."},{"key":"1727_CR27","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1523\/JNEUROSCI.0802-09.2009","volume":"29","author":"D Lau","year":"2009","unstructured":"Lau, D. & Bading, H. Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J. Neurosci. 29, 4420\u20134429 (2009).","journal-title":"J. Neurosci."},{"key":"1727_CR28","doi-asserted-by":"publisher","first-page":"18055","DOI":"10.1073\/pnas.1419083111","volume":"111","author":"P Merlo","year":"2014","unstructured":"Merlo, P. et al. p53 prevents neurodegeneration by regulating synaptic genes. Proc. Natl Acad. Sci. USA 111, 18055\u201318060 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1727_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nmd.2011.09.007","volume":"22","author":"M Bowerman","year":"2012","unstructured":"Bowerman, M., Murray, L. M., Beauvais, A., Pinheiro, B. & Kothary, R. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul. Disord. 22, 263\u2013276 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"1727_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052605","volume":"7","author":"SR Thomson","year":"2012","unstructured":"Thomson, S. R. et al. Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS ONE 7, e52605 (2012).","journal-title":"PLoS ONE"},{"key":"1727_CR31","doi-asserted-by":"publisher","first-page":"8774","DOI":"10.1523\/JNEUROSCI.2315-06.2006","volume":"26","author":"TW Gould","year":"2006","unstructured":"Gould, T. W. et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26, 8774\u20138786 (2006).","journal-title":"J. Neurosci."},{"key":"1727_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neuron.2016.10.061","volume":"92","author":"M Maor-Nof","year":"2016","unstructured":"Maor-Nof, M. et al. Axonal degeneration is regulated by a transcriptional program that coordinates expression of pro- and anti-degenerative factors. Neuron 92, 991\u20131006 (2016).","journal-title":"Neuron"},{"key":"1727_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.conb.2016.05.002","volume":"39","author":"MJ Geden","year":"2016","unstructured":"Geden, M. J. & Deshmukh, M. Axon degeneration: context defines distinct pathways. Curr. Opin. Neurobiol. 39, 108\u2013115 (2016).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1727_CR34","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1002\/j.1460-2075.1996.tb00834.x","volume":"15","author":"P Lassus","year":"1996","unstructured":"Lassus, P., Ferlin, M., Piette, J. & Hibner, U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J. 15, 4566\u20134573 (1996).","journal-title":"EMBO J."},{"key":"1727_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/sj.ejhg.5201556","volume":"14","author":"MS Tsai","year":"2006","unstructured":"Tsai, M. S., Chiu, Y. T., Wang, S. H., Hsieh-Li, H. M. & Li, H. Abolishing Trp53-dependent apoptosis does not benefit spinal muscular atrophy model mice. Eur. J. Hum. Genet. 14, 372\u2013375 (2006).","journal-title":"Eur. J. Hum. Genet."},{"key":"1727_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/exnr.2000.7464","volume":"165","author":"Ct Kuntz","year":"2000","unstructured":"Kuntz, Ct, Kinoshita, Y., Beal, M. F., Donehower, L. A. & Morrison, R. S. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 165, 184\u2013190 (2000).","journal-title":"Exp. Neurol."},{"key":"1727_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbadis.2010.01.011","volume":"1802","author":"LF Barbosa","year":"2010","unstructured":"Barbosa, L. F. et al. Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS. Biochim. Biophys. Acta 1802, 462\u2013471 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"1727_CR38","first-page":"401","volume":"78","author":"SM de la Monte","year":"1998","unstructured":"de la Monte, S. M., Sohn, Y. K., Ganju, N. & Wands, J. R. P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab. Invest. 78, 401\u2013411 (1998).","journal-title":"Lab. Invest."},{"key":"1727_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2007.02.088","volume":"1150","author":"DJ Eve","year":"2007","unstructured":"Eve, D. J., Dennis, J. S. & Citron, B. A. Transcription factor p53 in degenerating spinal cords. Brain Res. 1150, 174\u2013181 (2007).","journal-title":"Brain Res."},{"key":"1727_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2014.03.075","volume":"569","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. TDP-43 interaction with the intracellular domain of amyloid precursor protein induces p53-associated apoptosis. Neurosci. Lett. 569, 131\u2013136 (2014).","journal-title":"Neurosci. Lett."},{"key":"1727_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.braindev.2010.06.009","volume":"33","author":"Y Ito","year":"2011","unstructured":"Ito, Y., Shibata, N., Saito, K., Kobayashi, M. & Osawa, M. New insights into the pathogenesis of spinal muscular atrophy. Brain Dev. 33, 321\u2013331 (2011).","journal-title":"Brain Dev."},{"key":"1727_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0086-4","volume":"8","author":"A Piras","year":"2017","unstructured":"Piras, A. et al. Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy. Cell Death. Dis. 8, 3223 (2017).","journal-title":"Cell Death. Dis."},{"key":"1727_CR43","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ymthe.2006.02.008","volume":"13","author":"MS Tsai","year":"2006","unstructured":"Tsai, M. S. et al. Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice. Mol. Ther. 13, 1149\u20131155 (2006).","journal-title":"Mol. Ther."},{"key":"1727_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1727-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1727-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1727-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:14:03Z","timestamp":1671210843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1727-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1727-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"19 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"515"}}